Dolan Christine 4
4 · MARAVAI LIFESCIENCES HOLDINGS, INC. · Filed May 22, 2026
Research Summary
AI-generated summary of this filing
Maravai (MRVI) EVP Christine Dolan Receives 5,006 Shares
What Happened
Christine Dolan, Executive Vice President & General Manager, Cygnus Technologies at Maravai LifeSciences (MRVI), acquired 5,006 shares of Maravai Class A common stock on 2026-05-15. The shares were purchased under the company’s 2020 Employee Stock Purchase Plan at $1.79 per share for a total of $8,961. This was an acquisition (purchase/award) rather than a sale.
Key Details
- Transaction date: 2026-05-15; Price: $1.79 per share; Shares acquired: 5,006; Total value: $8,961.
- Purchase was made under the Maravai 2020 Employee Stock Purchase Plan (ESPP).
- Footnote: The acquisition was reported as exempt under Rule 16b-3 (per the filing).
- Shares owned after the transaction: not specified in this Form 4 filing.
- Filing date: 2026-05-22 (the Form 4 was filed seven days after the transaction), which is later than the typical 2-business-day filing deadline for Form 4s.
Context
This was a purchase via an employee plan (ESPP) — a routine way for employees to acquire company stock. The amount is modest (~$9k); such purchases can be interpreted as mildly positive but are not a definitive signal of broader insider sentiment. No options were exercised and no sales were reported in this filing.
Insider Transaction Report
- Award
Class A Common Stock
[F1]2026-05-15$1.79/sh+5,006$8,961→ 425,318 total
Footnotes (1)
- [F1]The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 5,006 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.